aspirin has been researched along with Hepatitis C, Chronic in 6 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "More information is needed about the long-term effects of low-dose aspirin (≤160 mg) on incident hepatocellular carcinoma, liver-related mortality, and gastrointestinal bleeding in persons with chronic hepatitis B or hepatitis C virus infection." | 7.96 | Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality. ( Aleman, S; Chan, AT; Chung, RT; Duberg, AS; Ludvigsson, JF; Simon, TG, 2020) |
| "Aspirin therapy has been associated with reduced risk of colon cancer, but there is only limited evidence for its effects on risk of hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC)." | 7.96 | Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection. ( Hsu, YC; Lee, TY; Lin, JT; Tseng, HC; Wu, CY; Wu, MS, 2020) |
| "More information is needed about the long-term effects of low-dose aspirin (≤160 mg) on incident hepatocellular carcinoma, liver-related mortality, and gastrointestinal bleeding in persons with chronic hepatitis B or hepatitis C virus infection." | 3.96 | Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality. ( Aleman, S; Chan, AT; Chung, RT; Duberg, AS; Ludvigsson, JF; Simon, TG, 2020) |
| "Aspirin therapy has been associated with reduced risk of colon cancer, but there is only limited evidence for its effects on risk of hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC)." | 3.96 | Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection. ( Hsu, YC; Lee, TY; Lin, JT; Tseng, HC; Wu, CY; Wu, MS, 2020) |
| "Liver fibrosis was assessed by histological evaluation." | 1.40 | Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation. ( Boëlle, PY; Chazouillères, O; Conti, F; Corpechot, C; Durand, F; Duvoux, C; Mackiewicz, V; Paradis, V; Poujol-Robert, A; Poupon, R; Wendum, D, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simon, TG | 1 |
| Duberg, AS | 1 |
| Aleman, S | 1 |
| Chung, RT | 1 |
| Chan, AT | 1 |
| Ludvigsson, JF | 1 |
| Lee, TY | 1 |
| Hsu, YC | 1 |
| Tseng, HC | 1 |
| Lin, JT | 1 |
| Wu, MS | 1 |
| Wu, CY | 1 |
| Scudiero, F | 1 |
| Valenti, R | 1 |
| Marcucci, R | 1 |
| Sanna, GD | 1 |
| Gori, AM | 1 |
| Migliorini, A | 1 |
| Vitale, R | 1 |
| Giusti, B | 1 |
| De Vito, E | 1 |
| Corda, G | 1 |
| Paniccia, R | 1 |
| Zirolia, D | 1 |
| Canonico, ME | 1 |
| Parodi, G | 1 |
| Poujol-Robert, A | 1 |
| Boëlle, PY | 1 |
| Conti, F | 1 |
| Durand, F | 1 |
| Duvoux, C | 1 |
| Wendum, D | 1 |
| Paradis, V | 1 |
| Mackiewicz, V | 1 |
| Chazouillères, O | 1 |
| Corpechot, C | 1 |
| Poupon, R | 1 |
| Bertuccio, SN | 1 |
| Rombolà, F | 1 |
| Bertuccio, A | 1 |
| Ranieri, FS | 1 |
| Füessl, HS | 1 |
6 other studies available for aspirin and Hepatitis C, Chronic
| Article | Year |
|---|---|
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Hepatocellular; Female; Gastroin | 2020 |
Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection.
Topics: Aged; Antiviral Agents; Aspirin; Carcinoma, Hepatocellular; Cohort Studies; Hepatitis C, Chronic; Hu | 2020 |
Platelet Reactivity in Hepatitis C Virus-Infected Patients on Dual Antiplatelet Therapy for Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Hepacivirus; | 2020 |
Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation.
Topics: Aspirin; Disease Progression; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Transplan | 2014 |
HCV infection and pericarditis: an extrahepatic manifestation?
Topics: Acute Disease; Adult; Aspirin; Electrocardiography; Follow-Up Studies; Hepacivirus; Hepatitis C Anti | 2005 |
[Family practice highlights of stomach, liver and intestinal reference points. Your arsenal against abdominal problems].
Topics: Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Barrett Esophagus; Family Practi | 2007 |